Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Performer
1567.5000 30.60 (1.99%)
NSE Jun 08, 2026 12:39 PM
Volume: 179.8K
 

1567.50
1.99%
Geojit BNP Paribas
EBITDA rose 16.4% YoY to Rs. 179cr, and the margin expanded 140 basis points (bps) YoY to 27.2%, driven by sustained volume growth, network expansion and a favourable mix, combined with the efficient hub-and-spoke model and technology...
Number of FII/FPI investors decreased from 378 to 351 in Mar 2026 qtr
More from Dr. Lal Pathlabs Ltd.
Recommended